Nanobiotix S.A. (NBTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NBTX currently has 48.4M outstanding shares. with limited dilution risk as only 5.62M additional shares (11.6%) are authorized for issuance. The company has minimally diluted shareholders by 2.7% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 31, 2026 |
20-F filing | 48.4M shares outstanding |
48M | 5.6M |
| Apr 02, 2025 |
20-F filing | 47.4M shares outstanding |
47M | 5.6M |
| Mar 06, 2025 |
F-3 filing: This is an F-3 filing for a shelf offering of ordinary shares and preferred shares, including ordinary shares in the form of American Depositary Shares, up to $200,000,000, and an additional offering of up to 5,623,816 ordinary shares by the selling shareholder. |
47M | 5.6M |
| Apr 24, 2024 |
20-F filing | 47.1M shares outstanding |
47M | 0 |
| Apr 24, 2023 |
20-F filing | 34.9M shares outstanding |
35M | 0 |
| Apr 08, 2022 |
20-F filing | 34.8M shares outstanding |
35M | 0 |
| Feb 04, 2022 |
F-3 filing: Nanobiotix S.A. files an F-3 form for a shelf offering of ordinary shares (including Ordinary Shares in the Form of American Depositary Shares) and warrants up to $200,000,000. |
34M | 0 |
| Apr 07, 2021 |
20-F filing | 34.4M shares outstanding |
34M | 0 |
| Nov 20, 2020 |
F-1 filing: This is an F-1 filing for an offering of ordinary shares to be in the form of ADSs. |
N/A | 0 |